Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haplo-identical Stem Cell Transplantation”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Looking for participantsNCT05126849
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

Who this might be right for
Refractory Idiopathic Aplastic AnemiaHaploidentical Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 31
Large-scale testing (Phase 3)UnknownNCT06000982
What this trial is testing

Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

Who this might be right for
GVHD
Shanghai Jiao Tong University School of Medicine 138
Early research (Phase 1)UnknownNCT04886206
What this trial is testing

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia (AML)
Nantes University Hospital 12
Large-scale testing (Phase 3)UnknownNCT03631563
What this trial is testing

ATG-F VS ATG for the Prevention of GVHD

Who this might be right for
GVHD in the Setting of Haplo-HSCT
Fujian Medical University 120
Testing effectiveness (Phase 2)UnknownNCT01156350
What this trial is testing

Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma

Who this might be right for
Neuroblastoma
University Hospital, Clermont-Ferrand 10
Early research (Phase 1)Study completedNCT03862833
What this trial is testing

Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nantes University Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT05855707
What this trial is testing

Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis

Who this might be right for
Allogeneic DiseaseGVHD,AcuteGraft Failure
Central Hospital, Nancy, France 12
Testing effectiveness (Phase 2)Looking for participantsNCT03520647
What this trial is testing

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Who this might be right for
Severe Aplastic Anemia (SAA)Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)
National Heart, Lung, and Blood Institute (NHLBI) 56
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableLooking for participantsNCT06089850
What this trial is testing

Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors

Who this might be right for
Haplo-identical TransplantationTransplantation
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Study completedNCT00104975
What this trial is testing

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Yale University 20
Not applicableUnknownNCT01719341
What this trial is testing

Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia

Who this might be right for
Haematological MalignanciesAcquired Aplastic Anaemia
National University Hospital, Singapore 21
Large-scale testing (Phase 3)Study completedNCT03719534
What this trial is testing

Haplo HCT vs Haplo-cord HCT for Patients With AML

Who this might be right for
Hematopoietic Stem Cell TransplantationHaplo-identical DonorCord Blood Unit+1 more
The First Affiliated Hospital of Soochow University 134
Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Testing effectiveness (Phase 2)Ended earlyNCT02127892
What this trial is testing

SCID Bu/Flu/ATG Study With T Cell Depletion

Who this might be right for
Severe Combined Immunodeficiency
Neena Kapoor, M.D. 9
Not applicableStudy completedNCT05243498
What this trial is testing

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationHaplo-identical
Central Hospital, Nancy, France 80
Testing effectiveness (Phase 2)Looking for participantsNCT03670966
What this trial is testing

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia in Remission+9 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05664126
What this trial is testing

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Who this might be right for
CytomegalovirusAdenovirus
St. Jude Children's Research Hospital 42
Large-scale testing (Phase 3)Study completedNCT02042690
What this trial is testing

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Peking University 131
Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3
Next Page